Alfaisal University signed an agreement with Hikma Pharmaceutical, a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. Hikma creates high-quality medicines and makes them accessible to the people in need, it also helps to shape a healthier world that enriches all our communities. Hikma is a dependable source of over 760 high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians, and pharmacists need to treat patients across North America, MENA, and Europe. It has 32 manufacturing facilities, 8 R&D centers, and c8,80 employees worldwide.
This agreement was signed by Dr. Yousef Alyousef, Vice President for Graduate Studies, Research & Innovation, and Mr. Eyad Abuawad, VP, General Manager at Hikma-KSA.
